Skip to main content

What the FDA labels say about taking them together

Phenobarbital and sirolimus

Sirolimus's FDA label of January 28, 2026 names phenobarbital in its drug interactions section; the phenobarbital labels PlainMeds reads (2) do not name sirolimus. The sirolimus label: “Drugs and other agents that could decrease sirolimus concentrations: Carbamazepine, phenobarbital, phenytoin, rifapentine, St. John’s Wort ( Hypericum perforatum )”

Check it at the source: the phenobarbital FDA label on DailyMed (effective August 27, 2026); the sirolimus FDA label on DailyMed (effective January 28, 2026, Glenmark Pharmaceuticals Inc., USA).

What does the phenobarbital label say about sirolimus?

Phenobarbital's label (effective August 27, 2026) and its 1 other brand-application label do not name sirolimus in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Phenobarbital), Chartwell RX, LLC, effective August 27, 2026 (SPL set 74428144-fb24-40a5-a670-3b876e2d116c), via openFDA; the full label on DailyMed

What does the sirolimus label say about phenobarbital?

Sirolimus label, drug interactions

Drugs and other agents that could decrease sirolimus concentrations: Carbamazepine, phenobarbital, phenytoin, rifapentine, St. John’s Wort ( Hypericum perforatum )

Source: FDA drug label (sirolimus), Glenmark Pharmaceuticals Inc., USA, effective January 28, 2026 (SPL set 57fb4d90-3ccb-4a69-af1e-53be83f7a504), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

0Phenobarbital generic labelers
17Sirolimus generic labelers
PhenobarbitalSirolimus
Labeled forSeizures and epilepsyOrgan transplant rejection
Boxed warningNoYes
Pharmacy cost (NADAC)$0.213 per tablet 100 mg tablet$0.723 per tablet 1 mg tablet
Shortage nowA presentation being discontinuedNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?